| 941685-27-4 Basic information More.. |
Product Name: | 4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine | Synonyms: | 4-(1H-PYRAZOL-4-YL)-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE;trimethyl-[2-[[4-(1H-pyrazol-4-yl)pyrrolo[2,3-d]pyrimidin-7-yl]methoxy]ethyl]silane;4-(1H-pyrazol-4-yl)-7-((2-trimethylsilanylethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine;-7-((2-(trimethylsilyl);Barretinib Intermediate 1;CS-1703;4-(4-Pyrazolyl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine;4-(1H-pyrazol-4-yl)-7-((2-trimethylsilanylethoxy)methyl)-7H-pyrrolo[2,3-d]p | CAS: | 941685-27-4 | MF: | C15H21N5OSi | MW: | 315.45 | EINECS: | 801-232-2 | Mol File: | 941685-27-4.mol |  |
Use
4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine is an important intermediate in the preparation of the janus kinase inhibitor INCB018424.
- INCB032304
-
- US $35.00 / mL
- 2025-05-02
- CAS:941685-27-4
- Min. Order:
- Purity: 100%
- Supply Ability: 10g
|
941685-27-4
Recommend Suppliers |
|